000 01268 a2200361 4500
005 20250518075832.0
264 0 _c20200114
008 202001s 0 0 eng d
022 _a1791-7530
024 7 _a10.21873/anticanres.13936
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWendt, Edgar Heinz Uwe
245 0 0 _aGalloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
_h[electronic resource]
260 _bAnticancer research
_cJan 2020
300 _a153-160 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBiomarkers
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aIsocoumarins
_xpharmacology
650 0 4 _aLactic Acid
_xmetabolism
650 0 4 _aMetformin
_xpharmacology
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
700 1 _aSchoenrogge, Maria
700 1 _aVollmar, Brigitte
700 1 _aZechner, Dietmar
773 0 _tAnticancer research
_gvol. 40
_gno. 1
_gp. 153-160
856 4 0 _uhttps://doi.org/10.21873/anticanres.13936
_zAvailable from publisher's website
999 _c30474846
_d30474846